Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial

BACKGROUND: Identifying patients with metastatic colorectal cancer who will have an early disease progression during induction chemotherapy (IC) and identifying patients who may have a chemotherapy-free interval (CFI) after IC are two major challenges. METHODS: A logistic model was used to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Aparicio, Thomas, Bennouna, Jaafar, Le Malicot, Karine, Boige, Valérie, Taieb, Julien, Bouché, Olivier, Phelip, Jean-Marc, François, Eric, Borel, Christian, Faroux, Roger, Dahan, Laetitia, Bachet, Jean-Baptiste, Egreteau, Joelle, Kaminsky, Marie-Christine, Gornet, Jean-Marc, Cojocarasu, Oana, Gasmi, Mohamed, Guerin-Meyer, Véronique, Lepage, Côme, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109054/
https://www.ncbi.nlm.nih.gov/pubmed/32015513
http://dx.doi.org/10.1038/s41416-020-0735-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109054/
https://www.ncbi.nlm.nih.gov/pubmed/32015513
http://dx.doi.org/10.1038/s41416-020-0735-8

Ejemplares similares